首页>
外国专利>
THERAPEUTIC AGENT FOR INTRACTABLE LEUKEMIA
THERAPEUTIC AGENT FOR INTRACTABLE LEUKEMIA
展开▼
机译:难治性白血病的治疗剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides a therapeutic composition for intractable leukemia comprising a drug (a) and a drug (b), wherein the drug (a) is a compound represented by the following formula (I), a salt thereof, or a prodrug thereof:; ;wherein, Ar1 is a substituted or unsubstituted arylene group;Ar2 is a substituted or unsubstituted aryl group or a substituted or unsubstituted aralkyl group;L is an oxygen atom, —NHCO—, or —CONH—;X1 is CH;X2 and X3 are CH and a nitrogen atom, respectively;Y is an ethylene group;m is 0; andZ1 and Z2 form a substituted or unsubstituted monocyclic heterocyclic group comprising X3 and having two nitrogen atoms as ring members, andthe drug (b) is a steroidal anti-inflammatory drug; and relates to a therapy for intractable leukemia.展开▼
机译:本发明提供了一种用于治疗顽固性白血病的药物组合物,其包含药物(a)和药物(b),其中所述药物(a)为下式(I)表示的化合物,其盐或前药: ; 化学> ;其中Ar 1 Sub>是取代或未取代的亚芳基; Ar 2 Sub>是取代或未取代的芳基或取代或未取代的芳烷基; ListItem> L是氧原子,-NHCO-或-CONH-; ListItem> X 1 Sub>是CH; ListItem> < ListItem id =“ ul0002-0004” number =“ 0000”> X 2 Sub>和X 3 Sub>分别是CH和一个氮原子; ListItem> Y是亚乙基; ListItem> m为0;和 ListItem> Z 1 Sub>和Z 2 Sub>组成取代或未取代的单环杂环基,其中X < Sub> 3 Sub>并且具有两个氮原子作为环成员,并且 ListItem> 药物(b)是甾体类抗炎药;并与难治性白血病的治疗有关。 ListItem> UnorderedList> ListItem> UnorderedList>
展开▼